Clinical Trials Logo
  1. Home
  2. Intestinal Barrier Function
  3. NCT01686204

Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt

Chronic Inflammation Clinical Trial

Official title:
Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt

Clinical Trial Summary

The main objective of this work is to conduct a clinical trial in obese and non-obese individuals testing the ability of low-fat dairy yogurt to improve gastrointestinal health and reduce chronic inflammation. Our central hypothesis is that short and long-term consumption of low-fat dairy yogurt will reduce inflammation to a greater extent in obese individuals by improving intestinal barrier function.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01686204
Study type Interventional
Source University of Wisconsin, Madison
Contact
Status Completed
Phase N/A
Start date September 2012
Completion date March 31, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Recruiting NCT05068557 - EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish) N/A
Not yet recruiting NCT05050812 - The Grounded Brain: How Sleeping Grounded Affects Memory and Perceptions N/A
Recruiting NCT02395354 - Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease N/A
Completed NCT02963662 - Impact of Gut Hormones and Inflammatory Adipokines in Obese Patients Underwent Bariatric Surgery N/A
Recruiting NCT05304689 - Analysis of the Relationship Between the Quantitative Index of Cytokines in the Oral Fluid and Inflammation N/A
Recruiting NCT06401785 - To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases Phase 2
Completed NCT05209867 - Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV Phase 4
Terminated NCT00211471 - Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). Phase 2
Recruiting NCT04447144 - Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome
Not yet recruiting NCT06444763 - Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population Phase 3
Completed NCT02506192 - Gulf War Illness Inflammation Reduction Trial Phase 2
Terminated NCT02661295 - A Study of Ferric Citrate to Improve Inflammation and Lipid Levels Phase 4
Completed NCT04023318 - The BMI Project (Body, Mind, Inflammation) N/A
Recruiting NCT04971408 - Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury N/A
Enrolling by invitation NCT02520206 - Adenosylmethionine Metabolism in Human Inflammation N/A
Recruiting NCT05392582 - MicroRNA Regulation of Chronic Inflammation During Aging
Recruiting NCT04979130 - Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB) Phase 4
Completed NCT04636723 - Neuroinflammation in Chronic Systemic Symptoms (CSS)
Completed NCT02084381 - PERCI- Medium Cut Off (MCO) N/A